Clinical Trials
9 trialsNCT03432897 2025-07-08
337
Brown University
Phase 2 Terminated
NCT03763253 2025-02-07
IP2-ATLANTA
Imperial College London
Phase 2 Active not recruiting
NCT02716974 2022-08-04
oligo-mets
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00828308 2022-03-08
Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer
Brown University
Phase 2 Completed
NCT03541928 2021-04-06
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
The Methodist Hospital Research Institute
Phase 2 Unknown
NCT03211052 2017-07-07
NEPTUNE
Queen Mary University of London
Phase 2 Terminated
NCT00438464 2016-03-09
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT01531205 2014-11-05
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00080808 2012-07-30
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Completed